Original Article Midterm outcome mitomycin C augmented trabeculectomy open angle glaucoma versus angle closure glaucoma Devendra Maheshwari Swathi Kanduri Mohideen A Kadar Rengappa Ramakrishnan Madhavi R Pillai Purpose The purpose study evaluate efficacy safety Trabeculectomy Mitomycin C Open angle glaucoma versus Angle closure glaucoma Methods The medical records patients underwent Trabeculectomy Mitomycin C reviewed followed years divided groups group 1 Open Angle Glaucoma n 41 group 2 Angle Closure Glaucoma n 67 Success criterion measured Intraocular Pressure 21 mmHg qualified complete use Antiglaucoma medications Results A total number 108 eyes 137 patients undertaken Mean preoperative Intraocular pressure group 1 314 105 mmHg group 2 331 94 reduced 105 34 105 26 116 36 110 27 110 27 group 1 109 28 120 38 128 49 124 39 124 37 group 2 P value 0566 0032 0168 0049 0049 months years respectively P 0001 visit The number Antiglaucoma medications reduced 075 089 043 055 3 yrs P 0002 At 36 months followup overall 500 482 eyes achieved complete qualified success respectively Subgroup analysis showed success rate higher group 1 683 compared group 2 552 Overall complications hypotony 18 choroidal detachment 28 encapsulated bleb 28 bleb leakage 18 encountered Conclusion Primary Trabeculectomy Mitomycin C safe effective means controlling Intraocular Pressure groups good success low rates sightthreatening complications Key words Angle closure glaucoma Mitomycin C open angle glaucoma trabeculectomy Access article online Website wwwijoin DOI 104103ijoIJO_1328_18 PMID Quick Response Code Glaucoma multifactorial optic neuropathy characteristic acquired atrophy optic nerve loss retinal ganglion cells axons resulting characteristic visual field abnormalities Although hemodynamic factors ocular blood flow perfusion pressure reported associated development glaucoma intraocular pressure IOP remains date factor modifiable different treatment modalities topical eye drops laser procedure surgical intervention13 Surgery conducted maximum tolerated medications laser therapy fail control progression glaucomatous optic neuropathy Since late 1960s Trabeculectomy surgery choice improving aqueous outflow glaucomatous eyes regarded gold standard newer surgeries compared45 The longterm successful control IOP eyes undergone primary trabeculectomy ranged 48 98 depending followup time criteria define successful outcome513 In studies complete success terms IOP described IOP 21 mmHg medication The success Trabeculectomy surgery depends producing controlled scarlimited fistula stable maintain adequate aqueous outflow Factors associated Department Glaucoma Aravind Eye Hospital PostGraduate Institute Ophthalmology Tirunelveli Tamil Nadu India Correspondence Dr Devendra Maheshwari Department Glaucoma Aravind Eye Hospital PostGraduate Institute Ophthalmology Tirunelveli 627 001 Tamil Nadu India Email drdevmaheshwarigmailcom Manuscript received 250818 Revision accepted 040319 increased risk bleb failure include young age aphakia anterior segment neovascularization inflammation previously failed glaucoma filtering surgery prolonged exposure ocular hypotensive agents1417 Thus enhance surgical success pharmacologic modulation wound healing treatment 5Fluorouracil Mitomycin C MMC Trabeculectomy investigated early 1980s Chen applied MMC peroperatively trabeculectomy eye corneal leucoma traumatic glaucoma undergone penetrating keratoplasty antiglaucoma surgeries18 Several randomized controlled trials intraoperative MMC compared placebo Trabeculectomy revealed reduction relative risk surgical failure1922 This study designed evaluate longterm outcome trabeculectomy retrospectively series consecutive cases Open angle glaucoma OAG Angle closure glaucoma ACG undergone Trabeculectomy MMC The aim obtain information longterm IOP control progression visual field defects visual impairment need cataract surgery This open access journal articles distributed terms Creative Commons AttributionNonCommercialShareAlike 40 License allows remix tweak build work noncommercially long appropriate credit given new creations licensed identical terms For reprints contact reprintsmedknowcom Cite article Maheshwari D Kanduri S Kadar MA Ramakrishnan R Pillai MR Midterm outcome mitomycin C augmented trabeculectomy open angle glaucoma versus angle closure glaucoma Indian J Ophthalmol 20196710804 2019 Indian Journal Ophthalmology Published Wolters Kluwer Medknow July 2019 1081 trabeculectomy evaluate possible factors related outcome measures patients glaucoma There published studies literature comparing longterm outcomes Trabeculectomy MMC OAG ACG Therefore background study undertaken Methods This study involved retrospective analysis 137 patients 108 eyes underwent MMC augmented Trabeculectomy Aravind eye hospital Tirunelveli January 2013 December 2013 The mean followup period final visit 36 months After obtaining institutional committee approval records patients reviewed Exclusion criteria included patients followup period year insufficient hospital records congenital glaucoma significant ocular disease glaucoma concurrent cataract surgery Patients included study OAG ACG Primary secondary glaucoma underwent Trabeculectomy MMC In cases information followup obtained outpatient chart Preoperative data Postoperative data 1 3 6 12 18 24 36 months included patients age sex type glaucoma number type Antiglaucoma medications AGM duration medications preoperative IOP Goldmann applanation tonometer cupdisc ratio Bestcorrected visual acuity BCVA Snellens chart Aurochart digital vision chart version 2 Madurai Tamilnadu India visual fields 242 102 Humphrey Automated Perimetry Zeiss model Germany All surgeries performed Conventional Trabeculectomy technique A superior rectus bridle suturecorneal traction suture applied After fornixbased conjunctival flap created Tenons capsule dissected adequate cautery applied A sponge soaked MMC 02 mgml placed conjunctival flap removed 2 minutes The area irrigated copiously 1520 ml saline solution A halfthickness triangular scleral flap dissected Paracentesis 15degree blade A viscoelastic agent Anterior chamber AC entry keratome A block sclera bed including trabecular meshwork removed trabeculectomy punch Kellys punch A broadbased Peripheral iridectomy performed The scleral flap sutured 100 nylon releasable suture method The conjunctival flap closed 80 vicryl interrupted suturesWise technique Watertight closure performed leaks AC formed Bleb raised Postoperatively eye drops Dexoren S Dexamethasone 01 Chloramphenicol 05 Indoco Remedies Ltd Mumbai Maharashtra India tapered 8 times period 12 weeks eye drops Homide Homatropine 2 Aurolab Madurai Tamilnadu India 2 times 1 time day 15 days Injection Dexasone 2 ml Dexamethasone sodium phosphate Cadila Pharmaceuticals Ahmadabad Gujarat India stat given Any postoperative complicationsprocedures recorded Failure defined uncontrolled IOP 21 mmHg despite medical treatment additional intervention bleb revision repeat trabeculectomy diode laser cyclodestruction required Statistical analysis Mean Standard deviation SD Frequency summary information Chisquare test Fishers exact test assess association categorical variables Group comparison continuous variables Students ttest Mann Whitney U test P value 005 considered statistically significant Statistical analysis STATA 111 Texas USA Results A retrospective study comprising total number 108 eyes 137 patients undertaken Primary Trabeculectomies performed MMC period study 14 patients year followup excluded insufficient hospital records In total 41 eyes OAG group compared 67 eyes ACG group Demographic data study population presented Table 1 IOP Mean preoperative IOP 314 105 mmHg OAG group 331 94 mmHg ACG group P 0384 Table 1 Demographic data study population Characteristics All patients OAG ACG P Age Mean SD 562789 5690102 558881 Range Gender n Male Female Visual acuity log MAR 3277 3277 3976 64 593 44 407 31 756 33 492 10 244 34 508 Mean SD 032028 030030 034028 Range 0108 0108 01 Preoperative IOP mmHg Mean SD 325099 31441050 3315945 Range Preoperative medications 668 1668 658 Mean SD 075089 095089 063087 Range 03 03 03 Preoperative HFA MD Mean SD 2209893 2264915 2176884 Range 0523384 0523272 2123384 Preoperative HFA PSD Mean SD Range 739325 1321444 767323 693327 1321444 1561426 0566t 0007c 0382m 0384 0046 0622t 0257t Complete success defined IOP 21 mmHg additional medication qualified success defined IOP 21 mmHg medication SD standard deviation MD mean deviation PSD pattern standard deviation OAG open angle glaucoma ACG angle closure glaucoma cChi Square Test P 005 t paired t test m Mann Whitney Maheshwari et al MMC trabeculectomy open vs angle closure glaucoma 1082 Indian Journal Ophthalmology Volume 67 Issue 7 At final followup OAG group greater mean total IOP reduction compared ACG group 110 27 mmHg vs 124 37 P 0049 borderline statistical significance Table 2 Success failure rate followup visits Overall success rates complete qualified success 50 482 respectively Subgroup analysis showed complete success 683 OAG 552 ACG 36 months followup The failure rate 2 3 ACG group The success rate higher OAG group compared ACG group Table 3 Number AGM The number AGM decreased 09 08 03 05 P 00003 OAG group 06 08 04 05 P 03157 ACG group However OAG group statistically significant reduction AGM compared ACG group Postoperative complications On intergroup comparison Table 4 significant difference groups P 099 In immediate postoperative period month large proportion cases 416 raised IOP 21 mmHg Among patients 34th ACG 14th OAG underwent Argon laser suture lysis ALS In total OAG seven ACG required Releasable suture removal Also digital message performed eyes flat bleb groups In total 3 ACG developed Hypotony experienced spontaneous recovery Choroidal detachment CD developed 3 ACG 24 OAG subsided oral steroids ACG OAG treatment Bleb leakage developed eyes ACG Table 2 Comparison intraocular pressure open angle glaucoma vs angle closure glaucoma Visits OAG n41 ACG n67 P Mean SD Range Mean SD Range Preoperative 3144 1050 1668 3315 945 One month 1702 979 Three month 1058 349 Six month First year 1058 268 1163 366 Second year 1105 277 Third year P 1105 275 0001 236 524 716 526 519 518 1513 718 1094 286 1207 384 1288 498 1246 399 1240 379 0001 658 438 222 726 640 728 628 0384 0251 0566 0032 0168 0049 0049 OAG open angle glaucoma ACG angle closure glaucoma SD standard deviation P 005 Mann Whitney managed medically In total 3 ACG 24 OAG encapsulated bleb These eyes received bleb needling Intraocular lens implantation IOL performed 244 OAG 373 ACG year primary Trabeculectomy There significant P 0003 improvement Best corrected visual acuity BCVA ACG group compared OAG group final visit Discussion The principal aim study determine success rates longterm IOP control primary conventional Trabeculectomy MMC OAG vs ACG need treatment medical surgical Based clinical experience literature highrisk cases including young patients black patients eyes failed trabeculectomy trauma aphakia active uveitis neovascular glaucoma routine filtration surgery fail23 The goal filtering surgery reduce maintain IOP level prevent optic nerve damage visual field loss The common cause failure filtering surgery scarring filtration site excessive fibrosis24 Various antifibrotic agents increase success rates glaucoma filtration surgery particularly highrisk cases24 Since medical therapy equally effective surgical therapy preventing glaucomatous visual field progression according Collaborative Initial Glaucoma Treatment Study patients requiring surgery usually received AGM long time25 Aggressive medical therapy increases number inflammatory cells enhances risk external bleb scarring filtration surgery failure That reason types glaucoma patients practice including primary secondary received concurrent MMC application trabeculectomy25 We threeyear success rates IOP control primary Trabeculectomy OAG 683 group higher compared ACG 552 group This attributed postoperative complications PACG Group particularly number cataract extraction PACG group eventually led poor IOP control Cataract extraction reported elevated IOP posttrabeculectomy ACG eyes applicable study Moreover PACG eyes anatomical arrangements risk eye shallowflat AC aqueous misdirection cilochoroidal effusion In contrast study conducted Sihota et al showed tenyear success rates IOP control Primary Angle Closure Glaucoma PACG comparable Primary Open Angle Glaucoma POAG eyes26 Overall percentage eyes Table 3 Success failure rate followup visits Outcome Complete Qualified Failure First year 32 781 8 195 1 24 OAG n41 Second year 28 683 13 317 OAG open angle glaucoma ACG angle closure glaucoma Third year 28 683 13 317 First year 42 627 20 299 5 74 ACG n67 Second year 37 552 26 388 4 60 3rd year 37 552 28 418 2 30 July 2019 1083 Table 4 Comparison postoperative complications open angle glaucoma vs angle closure glaucoma Postoperative complications Hypotony CD Encapsulated bleb Bleb leakage OAG ACG Total P 0 1 24 1 24 0 2 30 2 30 2 30 2 30 2 18 3 28 3 28 2 18 0991 OAG open angle glaucoma ACG angle closure glaucoma CD Choroidal detachment 1Fishers exact test receiving AGM reduced groups study varies different studies ranging 1 4982729 Progressive visual field loss trabeculectomy documented insignificant final visit study visual field loss reported 5060 1022 years study conducted Sihota et al26 However followup lasted years In practice 62 eyes 574 developed complications hypotony CD bleb leak encapsulated bleb cataract comparable study conducted Ching et al 86 eyes 585 encountered complications25 In study overall incidences postoperative complications till final visit insignificant groups However results comparable PACG POAG groups study conducted Tan Fang et al30 In study eyes 18 developed hypotony CD 28 eyes developed encapsulated bleb similar study conducted Cheung et al24 This related MMC application filtering surgery leads formation thinwalled avascular blebs leading low outflow resistance overfiltration finally causing hypotony31 Also thinwalled blebs prone leakage subsequently leading development blebitis endophthalmitis In retrospective study trabeculectomy MMC eye 07 developed bleb leakage comparable case series eyes 18 developed bleb leakage32 In study cataract progression developed 481 324 underwent extraction In similar study conducted Rajiv et al 553 underwent subsequent cataract surgery trabeculectomy33 Cataract progression formation possibly related surgeryagingcaused accelerated MMC The exact etiology unknown In present study ALS performed 35 324 eyes releasable sutures 10 93 eyes In study conducted Bindlish et al ALS performed 357 eyes Whites33 A proper technique adopted control filtration releasable suture ALS prevent overfiltration early postoperative period In current study significant improvement BCVA ACG group compared OAG group This attributed higher number cataract surgeries performed ACG group There certain limitations study include retrospective design intermediate term followup loss followup Different experienced surgeons involved management difference surgeons factor All causes bias study Previous studies shown successful longterm outcomes IOP reduction Trabeculectomy setting OAG34 As result anatomic abnormalities accompany ACG increased risk severe postoperative complications aqueous misdirection following filtration surgery patients34 However studies literature compared longterm outcomes trabeculectomy MMC ACG vs OAG Conclusion In conclusion study suggests antifibrotic agent assisted Trabeculectomy achieves favorable midterm successful outcomes IOP control patients OAG compared ACG However longterm followup required evaluate tonometric outcomes In spite Trabeculectomy related complications managed effectively tailored regimen surgical outcome good normal eye Financial support sponsorship Nil Conflicts There conflicts References 1 Flammer J The vascular concept glaucoma Surv Ophthalmol 199438S36 2 Fechtner RD Weinreb RN Mechanisms optic nerve damage primary open angle glaucoma Surv Ophthalmol 1994392342 3 Yanagi M Kawasaki R Wang JJ Wong TY Crowston J Kiuchi Y Vascular risk factors glaucoma A review Clin Exp Ophthalmol 2011392528 4 Moster MR Trabeculectomy post op Staying track Review Ophthalmol 2013118 5 Watson PG Grierson I The place trabeculectomy treatment glaucoma Ophthalmology 19818817596 6 Jerndal T Lundström M 330 Trabeculectomies A followup study ½3 years Acta Ophthalmol Copenh 1977555262 7 DErmo F Bonomi L Doro D A critical analysis longterm results Trabeculectomy Am J Ophthalmol 19798882935 8 Mills KB Trabeculectomy A retrospective longterm followup 444 cases Br J Ophthalmol 1981657905 9 Akafo SK Goulstine DB Rosenhal AR Longterm post trabeculectomy intraocular pressure Acta Ophthalmol Copenh 1992703126 10 Vesti E Filtering blebs Follow trabeculectomy Ophthalmic Surg 19932424955 11 NouriMahdavi K Brigatti L Weitzman M Caprioli J Outcomes trabeculectomy primary openangle glaucoma Ophthalmology 199510217609 12 Vesti E Raitta C A review outcome trabeculectomy openangle glaucoma Ophthalmic Surg Lasers 19972812832 13 Jacobi PC Dietlein TS Krieglstein GK Primary trabeculectomy young adults Longterm clinical results factors influencing outcome Ophthalmic Surg Lasers 19993063746 14 Skuta GL Parrish RK 2nd Wound healing glaucoma filtering surgery Surv Ophthalmol 19873214970 15 Borisuth NS Phillips B Krupin T The risk profile glaucoma Maheshwari et al MMC trabeculectomy open vs angle closure glaucoma 1084 Indian Journal Ophthalmology Volume 67 Issue 7 filtration surgery Curr Opin Ophthalmol 1999101126 16 Sherwood MB Grierson I Millar L Hitchings RA Longterm morphologic effects antiglaucoma drugs conjunctiva Tenons capsule Glaucomatous patients Ophthalmology 19899632735 17 Lavin MJ Wormald RP Migdal CS Hitchings RA The influence prior therapy success trabeculectomy Arch Ophthalmol 199010815438 18 Chen CW Huang HT Bair JS Lee CC Trabeculectomy simultaneous topical application mitomycinC refractory glaucoma J Ocul Pharmacol 1990617582 19 Andreanos D Georgopoulos GT Vergados J Papaconstantinou D Liokis N Theodossiadis P Clinical evaluation effect mitomycinC reoperation primary open angle glaucoma Eur J Ophthalmol 199774954 20 Costa VP Comegno PE Vasconcelos JP Malta RF José NK Lowdose mitomycin trabeculectomy patients advanced glaucoma J Glaucoma 199651939 21 Martini E Laffi GL Sprovieri C Scorolli L Lowdosage mitomycin C adjunct trabeculectomy A prospective controlled study Eur J Ophthalmol 19977408 22 Turaçli E Gündüz K Aktan G Tamer C A comparative clinical trial mitomycin cyclosporine A trabeculectomy Eur J Ophthalmol 19966398401 23 Broadway DC Chang LP Trabeculectomy risk factors failure preoperative state conjunctiva J Glaucoma 20011023749 24 Cheung JC Wright MM Murali S Pederson JE Intermediate term outcome variable dose mitomycin C filtering surgery Ophthalmology 19971041439 25 Huang CY Tseng HY Wu KY Midterm outcome trabeculectomy adjunctive Mitomycin c glaucoma patients Taiwan J Ophthalmol 20133316 26 Sihota R Gupta V Agarwal HC Long term evaluation trabeculectomy primary open angle glaucoma chronic primary angle closure glaucoma Asian population Clin Exp Ophthalmol 200432238 27 Robinson DI Lertsumitkul S Billson FA Robinson LP Long term intraocular pressure control trabeculectomy A year life table Aust N Z J Ophthalmol 1993217985 28 Watson PG Jakeman C Ozturk M The complications trabeculectomy 20 year follow Send Eye Lond 1990442538 29 Lamping KA Bellows AR Hutchinson BT Afran SI Long term evaluation initial filtering surgery Ophthalmology 19869391101 30 Tan YL Tsou PF Tan GS Perera SA Ho CL Wong TT et al Postoperative complications glaucoma surgery primary angle closure glaucoma vs primary open angle glaucoma Arch Ophthalmol 201112998792 31 Lama PJ Fechtner RD Antifibrotics wound healing glaucoma surgery Surv Ophthalmol 20034831446 32 Lusthaus JA Kubay O Karim R Wechsler D Booth F Primary trabeculectomy mitomycin C Safety efficacy 2 years Clin Exp Ophthalmol 2010388318 33 Bindlish R Condon GP Schlosser JD DAntonio J Lauer KB Lehrer R Efficacy safety Mitomycin C primary trabeculectomy Ophthalmology 2002109133641 34 Song BJ Ramanathan M Morales E Law SK Giaconi JA C o l e m n A L e t l T r b e c u l e c t o m y n d c o m b n e d phacoemulsificationtrabeculectomy Outcomes risk factors failure primary angle closure glaucoma J Glaucoma 2016257639